The CDC is developing a protocol to allow the use of Bavarian Nordic’s Jynneos monkeypox vaccine in children, if it becomes necessary, according to agency meeting documents cited by Bloomberg in a June 23 report.
Read the full post on Becker's Hospital Review - Healthcare News
